Clinical trial
Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC
NCT03897946 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating Immunogenicity of a Birth Dose of HBV Vaccine in the DRC
- Lead sponsor
- University of North Carolina, Chapel Hill
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 20, 2019
- Completion date
- February 5, 2021
- Enrollment
- 569 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.